• No results found

Cover Page The handle http://hdl.handle.net/1887/47526

N/A
N/A
Protected

Academic year: 2021

Share "Cover Page The handle http://hdl.handle.net/1887/47526"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Cover Page

The handle http://hdl.handle.net/1887/47526 holds various files of this Leiden University dissertation.

Author: Nederpelt, I.

Title: Time is of the essence - investigating kinetic interactions between drug, endogenous neuropeptides and receptor

Issue Date: 2017-04-06

(2)

1

Time is of the essence

Investigating kinetic interactions between drug,

endogenous neuropeptides and receptor

(3)

2 Cover design: Rochelle Vergroesen & Indira Nederpelt

Cover art: Rochelle Vergroesen Thesis lay-out: Indira Nederpelt

Printing: GVO drukkers & vormgevers B.V., Ede

© Copyright, Indira Nederpelt, 2017 ISBN: 978-94-6332-161-7

All rights reserved. No part of this book may be reproduced in any form or by any means without permission of the author.

(4)

3

Time is of the essence

Investigating kinetic interactions between drug, endogenous neuropeptides and receptor

Proefschrift

Ter verkrijging van de graad van Doctor aan de Universiteit Leiden, op gezag van Rector Magnificus Prof. Dr. C.J.J.M. Stolker,

volgens besluit van het College voor Promoties te verdedigen op donderdag 6 April 2017 klokke 16:15 uur

Door Indira Nederpelt

Geboren te Rotterdam, Nederland In 1988

(5)

4 Promotor: Prof. Dr. A.P. IJzerman

Co-promotor: Dr. L.H. Heitman

Promotie commissie:

Prof. Dr. H. Irth (chair)

Prof. Dr. J.A. Bouwstra (secretary)

Dr. E.C. de Lange (assistant professor of pharmacology at the LACDR, Leiden University)

Prof. Dr. G. Vauquelin (professor of molecular pharmacology at the Vrije Universiteit Brussel)

Prof. Dr. R.A. Adan (professor of molecular pharmacology at the Utrecht Medical Centre)

The research described in this thesis was performed at the department of Medicinal Chemistry of the Leiden Academic Centre for Drug Research (LACDR), Leiden University (Leiden, The Netherlands). The research was financially supported by EU/EFPIA Innovative Medicines Initiative Joint Undertaking, K4DD grant n° 115366.

(6)

5

to my mother

(7)

6

(8)

7

Index

Chapter 1 General Introduction 9-24

Chapter 2 Kinetic profile of neuropeptide – receptor interactions 25-42

Chapter 3 Characterization of 12 GnRH peptide agonists – a kinetic perspective

43-70

Chapter 4 Persistent GnRH receptor activation in pituitary αT3-1 cells analyzed with a label-free technology

71-88

Chapter 5 Kinetic binding and activation profiles of endogenous tachykinins targeting the NK1 receptor

89-107

Chapter 6 From receptor binding kinetics to signal transduction; a missing link in predicting in vivo drug-action

108-127

Chapter 7 Conclusions and future perspectives 128-142

Summary 143-148

Samenvatting 149-154

List of publications 155-158

Curriculum Vitae 159-162

Acknowledgements 163-165

(9)

8

Referenties

GERELATEERDE DOCUMENTEN

The research described in this thesis was performed at the Division of Medicinal Chemistry of the Leiden/Amsterdam Center for Drug Research, Leiden University (Leiden,

The research described in this thesis was performed at the Division of Drug Delivery Technology of the Leiden Academic Centre for Drug Research (LACDR) and at the Leiden

The research described in this thesis was performed at the Division of Medicinal Chemistry of the Leiden/Amsterdam Center for Drug Research, Leiden University (Leiden,

The research described in this thesis was performed at the Division of Medicinal Chemistry of the Leiden/Amsterdam Center for Drug Research, Leiden University, the Netherlands,

the full kinetic profile, is crucial (Figure 1). We propose a new perspective to drug discovery, where increased attention is paid to 1) release frequency of endogenous ligands

17 drawback of functional assays predicting binding kinetics is that these only provide an indication for the dissociation rate of a ligand while the association rate might also be

the full kinetic profile, is crucial (Figure 1). We propose a new perspective to drug discovery, where increased attention is paid to 1) release frequency of endogenous ligands

The research described in this thesis was performed at the division of Drug Discovery and Safety of the Leiden Academic Centre for Drug Research (LACDR), Leiden University, The